6101 - 6110 of 6255 Results
Title
Year
- Fast decoding cell type–specific transcription factor binding landscape at single-nucleotide resolution2021OPENTitle: Fast decoding cell type–specific transcription factor binding landscape at single-nucleotide resolutionJournal Name: Genome ResearchPublisher: Cold Spring Harbor LaboratoryVol: 31Issue #: 4Start Page: 721End Page: 731Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1101/gr.269613.120Best OA location URL: https://genome.cshlp.org/content/31/4/721.full.pdfCitation Count: 26
- Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s disease2023OPENTitle: Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s diseaseJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-023-00374-wBest OA location URL: https://translationalneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s40035-023-00374-wCitation Count: 23
-
OPENTitle: Loss of tau expression attenuates neurodegeneration associated with α-synucleinopathyJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-022-00309-xBest OA location URL: https://translationalneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s40035-022-00309-xCitation Count: 13
-
OPENTitle: Genome-wide Analysis of Motor Progression in Parkinson DiseaseJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 9Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000200092Best OA location URL: https://ng.neurology.org/content/nng/9/5/e200092.full.pdfCitation Count: 5
- Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer’s disease-associated biomarkers alterations among de novo Parkinson’s disease patients: a prospective cohort study2023OPENTitle: Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer’s disease-associated biomarkers alterations among de novo Parkinson’s disease patients: a prospective cohort studyJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-023-02843-5Best OA location URL: https://jneuroinflammation.biomedcentral.com/counter/pdf/10.1186/s12974-023-02843-5Citation Count: 25
- Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson’s disease patients and healthy controls2023OPENTitle: Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson’s disease patients and healthy controlsJournal Name: BMC MedicinePublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12916-023-02994-5Best OA location URL: https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/s12916-023-02994-5Citation Count: 7
- Basal ganglia neurons in healthy and parkinsonian primates generate recurring sequences of spikes2023OPENTitle: Basal ganglia neurons in healthy and parkinsonian primates generate recurring sequences of spikesJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 129Issue #: 5Start Page: 1010End Page: 1020Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1152/jn.00265.2022Best OA location URL: https://doi.org/10.1152/jn.00265.2022Citation Count: 2
- Early Autonomic Symptoms Predict Functional Decline in Parkinson’s Disease Independent of Dopaminergic Therapy2022OPENTitle: Early Autonomic Symptoms Predict Functional Decline in Parkinson’s Disease Independent of Dopaminergic TherapyJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 22Issue #: 1Start Page: 15End Page: 23Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000525664Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9671814Citation Count: 3
-
OPENTitle: A step forward for LRRK2 inhibitors in Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 648Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.abq7374Best OA location URL: https://discovery.ucl.ac.uk/10150053/1/abq7374_acceptedversion.pdfCitation Count: 18
-
OPENTitle: Determinants of coping styles of people with Parkinson’s DiseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00548-3Best OA location URL: https://www.nature.com/articles/s41531-023-00548-3.pdfCitation Count: 2